Hmet-G Forte 2mg Tablet PR is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral glucose uptake and utilization, enhancing insulin sensitivity. This dual mechanism addresses hyperglycemia through complementary pathways, making Hmet-G Forte effective in patients inadequately controlled by diet, exercise, and monotherapy. The prolonged-release formulation ensures sustained plasma concentrations, promoting better glycemic control and reducing dosing frequency. It is recommended to be used alongside lifestyle modifications such as diet and exercise. Caution is advised in patients with renal or hepatic impairment, cardiovascular disease, or a history of lactic acidosis. Common adverse effects include gastrointestinal disturbances, hypoglycemia, and rarely, lactic acidosis. Regular monitoring of blood glucose, renal function, and hepatic parameters is essential during therapy. Hmet-G Forte should be prescribed and administered under medical supervision, with dosage adjustments tailored to individual patient response and tolerability to optimize therapeutic outcomes.